Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53


ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer.

Lane JA, Er V, Avery KNL, Horwood J, Cantwell M, Caro GP, Crozier A, Smith GD, Donovan JL, Down L, Hamdy FC, Gillatt D, Holly J, Macefield R, Moody H, Neal DE, Walsh E, Martin RM, Metcalfe C.

Cancer Prev Res (Phila). 2018 Nov;11(11):687-696. doi: 10.1158/1940-6207.CAPR-18-0147. Epub 2018 Oct 11.


A Platform To Enhance Quantitative Single Molecule Localization Microscopy.

Golfetto O, Wakefield DL, Cacao EE, Avery KN, Kenyon V, Jorand R, Tobin SJ, Biswas S, Gutierrez J, Clinton R, Ma Y, Horne DA, Williams JC, Jovanović-Talisman T.

J Am Chem Soc. 2018 Oct 10;140(40):12785-12797. doi: 10.1021/jacs.8b04939. Epub 2018 Sep 26.


Mechanically interlocked functionalization of monoclonal antibodies.

Bzymek KP, Puckett JW, Zer C, Xie J, Ma Y, King JD, Goodstein LH, Avery KN, Colcher D, Singh G, Horne DA, Williams JC.

Nat Commun. 2018 Apr 20;9(1):1580. doi: 10.1038/s41467-018-03976-5.


Impact of question order on prioritisation of outcomes in the development of a core outcome set: a randomised controlled trial.

Brookes ST, Chalmers KA, Avery KNL, Coulman K, Blazeby JM; ROMIO study group.

Trials. 2018 Jan 25;19(1):66. doi: 10.1186/s13063-017-2405-6.


Protocol for the systematic review of the reporting of transoral robotic surgery.

Main BG, Blencowe NS, Howes N, Cousins S, Avery KNL, Gormley A, Radford P, Elliott D, Byrne B, Wilson N, Hinchliffe R, Blazeby JM.

BMJ Open. 2018 Jan 23;8(1):e019198. doi: 10.1136/bmjopen-2017-019198.


Meditope-Fab interaction: threading the hole.

Bzymek KP, Ma Y, Avery KN, Horne DA, Williams JC.

Acta Crystallogr F Struct Biol Commun. 2017 Dec 1;73(Pt 12):688-694. doi: 10.1107/S2053230X17016272. Epub 2017 Nov 18.


Development of a single, practical measure of surgical site infection (SSI) for patient report or observer completion.

Macefield RC, Reeves BC, Milne TK, Nicholson A, Blencowe NS, Calvert M, Avery KN, Messenger DE, Bamford R, Pinkney TD, Blazeby JM.

J Infect Prev. 2017 Jul;18(4):170-179. doi: 10.1177/1757177416689724. Epub 2017 Feb 1.


Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC).

Wade J, Elliott D, Avery KNL, Gaunt D, Young GJ, Barnes R, Paramasivan S, Campbell WB, Blazeby JM, Birtle AJ, Stein RC, Beard DJ, Halliday AW, Donovan JL; ProtecT study group; CLASS study group; Chemorad study group; POUT study group; OPTIMA prelim study group; CSAW study group and ACST-2 study group.

Trials. 2017 Jul 17;18(1):327. doi: 10.1186/s13063-017-2048-7.


Post-diagnosis serum insulin-like growth factors in relation to dietary and lifestyle changes in the Prostate testing for cancer and Treatment (ProtecT) trial.

Er V, Biernacka K, Simpkin AJ, Martin RM, Jeffreys M, Emmett P, Gilbert R, Avery KNL, Walsh E, Davis M, Donovan JL, Neal DE, Hamdy FC, Holly JMP, Lane JA.

Cancer Causes Control. 2017 Aug;28(8):877-888. doi: 10.1007/s10552-017-0910-2. Epub 2017 Jun 23.


Engineering a high-affinity peptide binding site into the anti-CEA mAb M5A.

Zer C, Avery KN, Meyer K, Goodstein L, Bzymek KP, Singh G, Williams JC.

Protein Eng Des Sel. 2017 Jun 1;30(6):409-417. doi: 10.1093/protein/gzx016.


Adverse event reporting in surgical trials and early phase studies: the need for new and joint perspectives.

Avery KN, Brookes ST, Richards H, Potter S, Blom A, Hinchcliffe R, Blazeby JM; NIHR Biomedical Research Centre Surgical Innovation Theme.

BMJ. 2017 Apr 5;357:j1693. doi: 10.1136/bmj.j1693. No abstract available.


Development of a Core Outcome Set for Clinical Effectiveness Trials in Esophageal Cancer Resection Surgery.

Avery KNL, Chalmers KA, Brookes ST, Blencowe NS, Coulman K, Whale K, Metcalfe C, Blazeby JM; ROMIO Study Group; CONSENSUS Esophageal Cancer Working Group.

Ann Surg. 2018 Apr;267(4):700-710. doi: 10.1097/SLA.0000000000002204.


Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies.

Avery KN, Williamson PR, Gamble C, O'Connell Francischetto E, Metcalfe C, Davidson P, Williams H, Blazeby JM; members of the Internal Pilot Trials Workshop supported by the Hubs for Trials Methodology Research.

BMJ Open. 2017 Feb 17;7(2):e013537. doi: 10.1136/bmjopen-2016-013537. Review.


Core Outcomes for Colorectal Cancer Surgery: A Consensus Study.

McNair AG, Whistance RN, Forsythe RO, Macefield R, Rees J, Pullyblank AM, Avery KN, Brookes ST, Thomas MG, Sylvester PA, Russell A, Oliver A, Morton D, Kennedy R, Jayne DG, Huxtable R, Hackett R, Dutton SJ, Coleman MG, Card M, Brown J, Blazeby JM.

PLoS Med. 2016 Aug 9;13(8):e1002071. doi: 10.1371/journal.pmed.1002071. eCollection 2016 Aug.


Trial outcomes and information for clinical decision-making: a comparative study of opinions of health professionals.

McNair AG, Brookes ST, Whistance RN, Forsythe RO, Macefield R, Rees J, Jones J, Smith G, Pullyblank AM, Avery KN, Thomas MG, Sylvester PA, Russell A, Oliver A, Morton D, Kennedy R, Jayne DG, Huxtable R, Hackett R, Dutton SJ, Coleman MG, Card M, Brown J, Blazeby JM; CONSENSUS-CRC (Core Outcomes and iNformation SEts iN SUrgical Studies – ColoRectal Cancer) working group.

Trials. 2016 Jul 25;17(1):344. doi: 10.1186/s13063-016-1492-0.


Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.

Lane A, Metcalfe C, Young GJ, Peters TJ, Blazeby J, Avery KN, Dedman D, Down L, Mason MD, Neal DE, Hamdy FC, Donovan JL; ProtecT Study group.

BJU Int. 2016 Dec;118(6):869-879. doi: 10.1111/bju.13582. Epub 2016 Aug 17.


What surgeons tell patients and what patients want to know before major cancer surgery: a qualitative study.

McNair AGK, MacKichan F, Donovan JL, Brookes ST, Avery KNL, Griffin SM, Crosby T, Blazeby JM.

BMC Cancer. 2016 Mar 31;16:258. doi: 10.1186/s12885-016-2292-3.


A Systematic Review of Patient-reported Outcomes in Randomized Controlled Trials of Unplanned General Surgery.

Stevens DJ, Blencowe NS, McElnay PJ, Macefield RC, Savović J, Avery KN, Blazeby JM.

World J Surg. 2016 Feb;40(2):267-76. doi: 10.1007/s00268-015-3292-1. Review.


Assessing the quality of written information provision for surgical procedures: a case study in oesophagectomy.

Blencowe NS, Strong S, McNair AG, Howes N, Elliot J, Avery KN, Blazeby JM.

BMJ Open. 2015 Oct 12;5(10):e008536. doi: 10.1136/bmjopen-2015-008536.


Synthesis and summary of patient-reported outcome measures to inform the development of a core outcome set in colorectal cancer surgery.

McNair AG, Whistance RN, Forsythe RO, Rees J, Jones JE, Pullyblank AM, Avery KN, Brookes ST, Thomas MG, Sylvester PA, Russell A, Oliver A, Morton D, Kennedy R, Jayne DG, Huxtable R, Hackett R, Dutton SJ, Coleman MG, Card M, Brown J, Blazeby JM; CONSENSUS-CRC (Core Outcomes and iNformation SEts iN SUrgical Studies - ColoRectal Cancer) Working Group.

Colorectal Dis. 2015 Nov;17(11):O217-29. doi: 10.1111/codi.13021. Review.


Investigating the collection and assessment of patient-reported outcome data amongst unplanned surgical hospital admissions: a feasibility study.

Mason JD, Blencowe NS, McNair AG, Stevens DJ, Avery KN, Pullyblank AM, Blazeby JM.

Pilot Feasibility Stud. 2015 May 9;1:16. eCollection 2015.


Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial.

Wade J, Rosario DJ, Howson J, Avery KN, Salter CE, Goodwin ML, Blazeby JM, Lane JA, Metcalfe C, Neal DE, Hamdy FC, Donovan JL.

BMC Health Serv Res. 2015 Feb 28;15:80. doi: 10.1186/s12913-015-0729-z.


Development of a high affinity, non-covalent biologic to add functionality to Fabs.

Avery KN, Zer C, Bzymek KP, Williams JC.

Sci Rep. 2015 Jan 15;5:7817. doi: 10.1038/srep07817.


Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.

Küçük C, Jiang B, Hu X, Zhang W, Chan JK, Xiao W, Lack N, Alkan C, Williams JC, Avery KN, Kavak P, Scuto A, Sen E, Gaulard P, Staudt L, Iqbal J, Zhang W, Cornish A, Gong Q, Yang Q, Sun H, d'Amore F, Leppä S, Liu W, Fu K, de Leval L, McKeithan T, Chan WC.

Nat Commun. 2015 Jan 14;6:6025. doi: 10.1038/ncomms7025.


Men's knowledge and attitudes towards dietary prevention of a prostate cancer diagnosis: a qualitative study.

Horwood JP, Avery KN, Metcalfe C, Donovan JL, Hamdy FC, Neal DE, Lane JA.

BMC Cancer. 2014 Nov 5;14:812. doi: 10.1186/1471-2407-14-812.


Adherence to dietary and lifestyle recommendations and prostate cancer risk in the prostate testing for cancer and treatment (ProtecT) trial.

Er V, Lane JA, Martin RM, Emmett P, Gilbert R, Avery KN, Walsh E, Donovan JL, Neal DE, Hamdy FC, Jeffreys M.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2066-77. doi: 10.1158/1055-9965.EPI-14-0322. Epub 2014 Jul 13.


The feasibility of a randomized controlled trial of esophagectomy for esophageal cancer--the ROMIO (Randomized Oesophagectomy: Minimally Invasive or Open) study: protocol for a randomized controlled trial.

Avery KN, Metcalfe C, Berrisford R, Barham CP, Donovan JL, Elliott J, Falk SJ, Goldin R, Hanna G, Hollowood AA, Krysztopik R, Noble S, Sanders G, Streets CG, Titcomb DR, Wheatley T, Blazeby JM.

Trials. 2014 Jun 2;15:200. doi: 10.1186/1745-6215-15-200.


The importance of dietary change for men diagnosed with and at risk of prostate cancer: a multi-centre interview study with men, their partners and health professionals.

Avery KN, Donovan JL, Horwood J, Neal DE, Hamdy FC, Parker C, Wade J, Lane A.

BMC Fam Pract. 2014 May 3;15:81. doi: 10.1186/1471-2296-15-81.


Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).

Turner EL, Metcalfe C, Donovan JL, Noble S, Sterne JA, Lane JA, Avery KN, Down L, Walsh E, Davis M, Ben-Shlomo Y, Oliver SE, Evans S, Brindle P, Williams NJ, Hughes LJ, Hill EM, Davies C, Ng SY, Neal DE, Hamdy FC, Martin RM; CAP trial group.

Br J Cancer. 2014 Jun 10;110(12):2829-36. doi: 10.1038/bjc.2014.242. Epub 2014 May 27.


Psychological impact of prostate biopsy: physical symptoms, anxiety, and depression.

Wade J, Rosario DJ, Macefield RC, Avery KN, Salter CE, Goodwin ML, Blazeby JM, Lane JA, Metcalfe C, Neal DE, Hamdy FC, Donovan JL.

J Clin Oncol. 2013 Nov 20;31(33):4235-41. doi: 10.1200/JCO.2012.45.4801. Epub 2013 Oct 21.


Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies.

Donaldson JM, Zer C, Avery KN, Bzymek KP, Horne DA, Williams JC.

Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17456-61. doi: 10.1073/pnas.1307309110. Epub 2013 Oct 7.


A systematic review of outcome reporting in colorectal cancer surgery.

Whistance RN, Forsythe RO, McNair AG, Brookes ST, Avery KN, Pullyblank AM, Sylvester PA, Jayne DG, Jones JE, Brown J, Coleman MG, Dutton SJ, Hackett R, Huxtable R, Kennedy RH, Morton D, Oliver A, Russell A, Thomas MG, Blazeby JM; Core Outcomes and iNformation SEts iN SUrgical Studies - ColoRectal Cancer Working Group.

Colorectal Dis. 2013;15(10):e548-60. doi: 10.1111/codi.12378. Review.


Men with prostate cancer make positive dietary changes following diagnosis and treatment.

Avery KN, Donovan JL, Gilbert R, Davis M, Emmett P, Down L, Oliver S, Neal DE, Hamdy FC, Lane JA.

Cancer Causes Control. 2013 Jun;24(6):1119-28. doi: 10.1007/s10552-013-0189-x. Epub 2013 Mar 22.


Understanding surgical interventions in RCTs: the need for better methodology.

Avery KN, Barham CP, Berrisford R, Blazeby JM, Blencowe NS, Donovan J, Elliott J, Falk SJ, Goldin R, Hanna G, Hollowood AD, Metcalfe C, Noble S, Sanders G, Streets CG, Titcomb DR, Wheatley T.

Lancet. 2013 Jan 5;381(9860):27-8. doi: 10.1016/S0140-6736(13)60015-X. No abstract available.


Integration of clinical and patient-reported outcomes in surgical oncology.

Macefield RC, Avery KN, Blazeby JM.

Br J Surg. 2013 Jan;100(1):28-37. doi: 10.1002/bjs.8989. Epub 2012 Nov 20. Review.


Behavior theory for dietary interventions for cancer prevention: a systematic review of utilization and effectiveness in creating behavior change.

Avery KN, Donovan JL, Horwood J, Lane JA.

Cancer Causes Control. 2013 Mar;24(3):409-20. doi: 10.1007/s10552-012-9995-9. Epub 2012 May 22. Review.


A cross-sectional analysis of the association between diet and insulin-like growth factor (IGF)-I, IGF-II, IGF-binding protein (IGFBP)-2, and IGFBP-3 in men in the United Kingdom.

Young NJ, Metcalfe C, Gunnell D, Rowlands MA, Lane JA, Gilbert R, Avery KN, Davis M, Neal DE, Hamdy FC, Donovan J, Martin RM, Holly JM.

Cancer Causes Control. 2012 Jun;23(6):907-17. doi: 10.1007/s10552-012-9961-6. Epub 2012 Apr 21.


Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.

Avery KN, Metcalfe C, Vedhara K, Lane JA, Davis M, Neal DE, Hamdy FC, Donovan JL, Blazeby JM.

Eur Urol. 2012 Oct;62(4):649-55. doi: 10.1016/j.eururo.2011.12.059. Epub 2012 Jan 10.


Psychometric evaluation of a new patient-completed questionnaire for evaluating anal incontinence symptoms and impact on quality of life: the ICIQ-B.

Cotterill N, Norton C, Avery KN, Abrams P, Donovan JL.

Dis Colon Rectum. 2011 Oct;54(10):1235-50. doi: 10.1097/DCR.0b013e3182272128.


Reporting clinical outcomes of breast reconstruction: a systematic review.

Potter S, Brigic A, Whiting PF, Cawthorn SJ, Avery KN, Donovan JL, Blazeby JM.

J Natl Cancer Inst. 2011 Jan 5;103(1):31-46. doi: 10.1093/jnci/djq438. Epub 2010 Dec 3. Review.


Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result.

Macefield RC, Metcalfe C, Lane JA, Donovan JL, Avery KN, Blazeby JM, Down L, Neal DE, Hamdy FC, Vedhara K; ProtecT Study Group.

Br J Cancer. 2010 Apr 27;102(9):1335-40. doi: 10.1038/sj.bjc.6605648. Epub 2010 Apr 6.


Prognostic value of changes in health-related quality of life scores during curative treatment for esophagogastric cancer.

Djärv T, Metcalfe C, Avery KN, Lagergren P, Blazeby JM.

J Clin Oncol. 2010 Apr 1;28(10):1666-70. doi: 10.1200/JCO.2009.23.5143. Epub 2010 Mar 1.


Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?

Avery KN, Metcalfe C, Blazeby JM, Lane JA, Neal DE, Hamdy FC, Donovan JL.

BJU Int. 2008 Dec;102(11):1629-33. doi: 10.1111/j.1464-410X.2008.07879.x. Epub 2008 Aug 14.


The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review.

Parameswaran R, McNair A, Avery KN, Berrisford RG, Wajed SA, Sprangers MA, Blazeby JM.

Ann Surg Oncol. 2008 Sep;15(9):2372-9. doi: 10.1245/s10434-008-0042-8. Epub 2008 Jul 15. Review.


Patient-reported outcomes to evaluate surgery.

Avery KN, Gujral S, Blazeby JM.

Expert Rev Pharmacoecon Outcomes Res. 2008 Feb;8(1):43-50. doi: 10.1586/14737167.8.1.43.


Quality of life after surgery for colorectal cancer: clinical implications of results from randomised trials.

Gujral S, Avery KN, Blazeby JM.

Support Care Cancer. 2008 Feb;16(2):127-32. Epub 2007 Nov 20. Review.


A patient-centered approach to developing a comprehensive symptom and quality of life assessment of anal incontinence.

Cotterill N, Norton C, Avery KN, Abrams P, Donovan JL.

Dis Colon Rectum. 2008 Jan;51(1):82-7. Epub 2007 Nov 15.


Decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial.

Avery KN, Blazeby JM, Lane JA, Neal DE, Hamdy FC, Donovan JL.

Eur Urol. 2008 Jun;53(6):1186-93. Epub 2007 Aug 15.


Quality of life during potentially curative treatment for locally advanced oesophageal cancer.

Avery KN, Metcalfe C, Barham CP, Alderson D, Falk SJ, Blazeby JM.

Br J Surg. 2007 Nov;94(11):1369-76.


Health-related quality of life among patients cured by surgery for esophageal cancer.

Lagergren P, Avery KN, Hughes R, Barham CP, Alderson D, Falk SJ, Blazeby JM.

Cancer. 2007 Aug 1;110(3):686-93.

Supplemental Content

Loading ...
Support Center